Pneumologia

Obstrução laríngea induzida por exercício em atletas: revisão narrativa feita por um subgrupo do Consenso IOC sobre doença respiratória aguda no atleta.

6 Jul, 2022 | 11:09h

Exercise-induced laryngeal obstruction (EILO) in athletes: a narrative review by a subgroup of the IOC Consensus on ‘acute respiratory illness in the athlete’ – British Journal of Sports Medicine

---

M-A | Preditores de distúrbios respiratórios durante o sono em crianças com síndrome de Down.

6 Jul, 2022 | 10:43h

Predictors of sleep disordered breathing in children with Down syndrome: a systematic review and meta-analysis – European Respiratory Review

---

Revisão | Tosse por hipersensibilidade e tosse crônica.

5 Jul, 2022 | 12:03h

Cough hypersensitivity and chronic cough – Nature Reviews Disease Primers (se o acesso a este link for pago, tente este)

Ver também: Infographic (se o acesso a este link for pago, tente este)

 

Comentário no Twitter

#Cough is mediated by a complex set of neurobiological processes involving the peripheral nervous system, brainstem and higher brain. #ChronicCoughhttps://t.co/DGgjk2Iyji pic.twitter.com/nrmJne7Ir8

— Nature Reviews Disease Primers (@DiseasePrimers) July 2, 2022

---

Más notícias para a Paxlovid? Coronavírus pode encontrar múltiplas vias para escapar do medicamento para COVID-19.

5 Jul, 2022 | 12:01h

Bad news for Paxlovid? Coronavirus can find multiple ways to evade COVID-19 drug – Science

Ver também: SARS-CoV-2 can evade Paxlovid by multiple mechanisms – News Medical

---

Opinião | FDA: não faça nenhum movimento para mudar a composição da vacina contra Covid-19.

5 Jul, 2022 | 11:59h

FDA: Don’t rush a move to change the Covid-19 vaccine composition – STAT

---

Diretriz | Estratificação de risco de malignidade para nódulo pulmonar solitário.

5 Jul, 2022 | 11:45h

Malignancy risk stratification for solitary pulmonary nodule: A clinical practice guideline – Journal of Evidence-Based Medicine

---

Breve revisão | Pneumonia associada a ventilação mecânica.

5 Jul, 2022 | 11:32h

Ventilator-associated pneumonia – Intensive Care Medicine (se o acesso a este link for pago, tente este no PMC)

 

Comentário no Twitter

VAP, main challenges & lessons learned
➡️ epidemiology: surveillance & data from LMICs
➡️ pathophysiology
➡️ prevention bundle
➡️ gold standard for diagnosis & microbiology
➡️ treatment: appropriate/timely ABTs
➡️ MDR pathogens
➡️ #COVID19: VAP's back
📎 https://t.co/oYblI6OGLK pic.twitter.com/qXWcABsU0H

— Intensive Care Medicine (@yourICM) July 1, 2022

---

Diretrizes 2022 para o tratamento e a profilaxia do tromboembolismo venoso em pacientes com câncer, incluindo aqueles com COVID-19.

4 Jul, 2022 | 12:24h

2022 international clinical practice guidelines for the treatment and prophylaxis of venous thromboembolism in patients with cancer, including patients with COVID-19 – The Lancet Oncology

Conteúdos relacionados:

Primary prophylaxis for venous thromboembolism in ambulatory cancer patients receiving chemotherapy – Cochrane Library

American Society of Hematology 2021 guidelines for management of venous thromboembolism: prevention and treatment in patients with cancer – Blood Advances

Cancer-Associated Venous Thromboembolic Disease, Version 2.2021, NCCN Clinical Practice Guidelines in Oncology – Journal of the National Comprehensive Cancer Network

Venous and Arterial Thromboembolism in Patients With Cancer: JACC: CardioOncology State-of-the-Art Review

---

Dois novos estudos mostram que a enoxaparina não tem benefício na tromboprofilaxia primária de pacientes ambulatoriais sintomáticos com COVID-19.

4 Jul, 2022 | 12:23h

Estudo 1: Enoxaparin for primary thromboprophylaxis in symptomatic outpatients with COVID-19 (OVID): a randomised, open-label, parallel-group, multicentre, phase 3 trial – The Lancet Haematology

Estudo 2: Thromboprophylactic low-molecular-weight heparin versus standard of care in unvaccinated, at-risk outpatients with COVID-19 (ETHIC): an open-label, multicentre, randomised, controlled, phase 3b trial – The Lancet Haematology

Comentários:

Antithrombotic prophylaxis for symptomatic outpatients with COVID-19: less is consistently more – The Lancet Haematology

Antithrombotic Prophylaxis No Help in Outpatients With COVID — Two trials show no differences between patients who received enoxaparin vs standard of care – MedPage Today (necessário cadastro gratuito)

 

Comentário no Twitter (fio – clique para saber mais)

Early in the pandemic we wondered whether antithrombotic therapy in outpatients with #COVID19 would prevent #thrombosis ❓

Several trials were started globally and the ACTIV-4B trial was previously reported⬇️ https://t.co/Q15WcZwDIA

Now, we publish the OVID and ETHIC trials🧵

— The Lancet Haematology (@TheLancetHaem) June 30, 2022

 

---

Acurácia do teste rápido de antígeno vs. RT-PCR para infecção por SARS-CoV-2 em atletas universitários durante a prevalência da variante Ômicron.

4 Jul, 2022 | 12:18h

Accuracy of Rapid Antigen vs Reverse Transcriptase–Polymerase Chain Reaction Testing for SARS-CoV-2 Infection in College Athletes During Prevalence of the Omicron Variant – JAMA Network Open

 

Comentário no Twitter

In this case series of college athletes returning to campus during Omicron, rapid antigen tests were 63% sensitive, >99% specific for #COVID19, similar to previous strains and less well in detecting asymptomatic #SARSCoV2. @helixcardinal @stanford_ortho https://t.co/SBPr6NQ9Na

— JAMA Network Open (@JAMANetworkOpen) June 15, 2022

 

---